Warning! GuruFocus detected
1 Severe warning sign
with BDTX.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Black Diamond Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US09203E1055
Share Class Description:
BDTX: Ordinary SharesCompare
Compare
Traded in other countries / regions
BDTX.USA Index Membership
Russell 2000Russell 3000Russell 2000 IPO Date
2020-01-30Description
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.44 | |||||
| Equity-to-Asset | 0.68 | |||||
| Debt-to-Equity | 0.27 | |||||
| Debt-to-EBITDA | -0.28 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 25.9 | |||||
| 3-Year EPS without NRI Growth Rate | 28.5 | |||||
| 3-Year FCF Growth Rate | 26.4 | |||||
| 3-Year Book Growth Rate | -35.2 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 25.75 | |||||
| 9-Day RSI | 30.77 | |||||
| 14-Day RSI | 33.55 | |||||
| 3-1 Month Momentum % | -17.73 | |||||
| 6-1 Month Momentum % | -51.73 | |||||
| 12-1 Month Momentum % | -64.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.92 | |||||
| Quick Ratio | 4.92 | |||||
| Cash Ratio | 4.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -16.1 | |||||
| Shareholder Yield % | -27.67 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -67.94 | |||||
| ROA % | -48.96 | |||||
| ROIC % | -299.35 | |||||
| 3-Year ROIIC % | -647.17 | |||||
| ROC (Joel Greenblatt) % | -357.08 | |||||
| ROCE % | -64.02 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.95 | |||||
| Price-to-Tangible-Book | 0.95 | |||||
| EV-to-EBIT | -0.11 | |||||
| EV-to-EBITDA | -0.11 | |||||
| EV-to-FCF | -0.14 | |||||
| Price-to-Net-Current-Asset-Value | 1.28 | |||||
| Price-to-Net-Cash | 1.33 | |||||
| Earnings Yield (Greenblatt) % | -909.09 | |||||
| FCF Yield % | -78.54 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BDTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Black Diamond Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.27 | ||
| Beta | 3.67 | ||
| 3-Year Sharpe Ratio | 0.37 | ||
| 3-Year Sortino Ratio | 0.81 | ||
| Volatility % | 71.95 | ||
| 14-Day RSI | 33.55 | ||
| 14-Day ATR ($) | 0.184909 | ||
| 20-Day SMA ($) | 1.65475 | ||
| 12-1 Month Momentum % | -64.58 | ||
| 52-Week Range ($) | 1.36 - 7.66 | ||
| Shares Outstanding (Mil) | 56.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Black Diamond Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Black Diamond Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Black Diamond Therapeutics Inc Frequently Asked Questions
What is Black Diamond Therapeutics Inc(BDTX)'s stock price today?
The current price of BDTX is $1.40. The 52 week high of BDTX is $7.66 and 52 week low is $1.36.
When is next earnings date of Black Diamond Therapeutics Inc(BDTX)?
The next earnings date of Black Diamond Therapeutics Inc(BDTX) is 2025-05-09 Est..
Does Black Diamond Therapeutics Inc(BDTX) pay dividends? If so, how much?
Black Diamond Therapeutics Inc(BDTX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers